Latest Breaking News On - Michael spigarelli - Page 1 : comparemela.com

PsyBio Therapeutics Corp : PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale

PsyBio Therapeutics Corp : PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMichael spigarelliEvan levinePsybio therapeutics corpDrug administrationVenture exchangeRegulation services providerColorado newsfile corpBio therapeuticsChief medical officerChief scientificChief executiveInvestigational new drug applicationsUnited states foodDie experten

PsyBio Announces Closing of First Tranche of Private Placement Led by the Chairman and Chief Executive Officer with Participation from the Entire Board of Directors and Management Team and Provides Co

PsyBio Announces Closing of First Tranche of Private Placement Led by the Chairman and Chief Executive Officer with Participation from the Entire Board of Directors and Management Team and Provides Co
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNitin kaushalMichael spigarelliBob oliverNoah davisEvan levineCross carmelCompany the unitsPsybio therapeutics corpDrug administrationVenture exchangeRegulation services providerColorado newsfile corpBio therapeuticsEach unitCurrent good manufacturing practices

PsyBio Therapeutics Financing Inc : PsyBio Announces Closing of First Tranche of Private Placement Led by the Chairman and Chief Executive Officer with Participation from the Entire Board of Directors and Management Team and Provides Corporate Update

Oxford, Ohio and Denver, Colorado (Newsfile Corp. - January 5, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology

United statesNitin kaushalMichael spigarelliBob oliverNoah davisEvan levineCross carmelCompany the unitsPsybio therapeutics corpDrug administrationVenture exchangeRegulation services providerColorado newsfile corpBio therapeuticsEach unitCurrent good manufacturing practices

2022-05-06 | TSXV:PSYB | Press Release | PsyBio Therapeutics

(2022-05-06 | TSXV:PSYB) PsyBio Therapeutics Initiates Blood-Brain Barrier Permeability Testing for Pipeline Compounds to Enhance Portfolio Development

United statesMichael spigarelliEvan levinePsybio therapeutics corpLesotho companyEverest pharma pty ltdDrug administrationPsybio therapeutics further expands testingBio therapeuticsInvestigational new drugChief medicalChief executiveEverest pharmaSouthern africaPsybio therapeuticsHealthcare 37

PsyBio Therapeutics Initiates Blood-Brain Barrier Permeability Testing for Pipeline Compounds to Enhance Portfolio Development

/CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), a fully integrated and intellectual property driven biotechnology.

United statesMichael spigarelliEvan levinePsybio therapeutics corpLesotho companyEverest pharma pty ltdDrug administrationPsybio therapeutics further expands testingBio therapeuticsInvestigational new drugChief medicalChief executiveEverest pharmaSouthern africaPsybio therapeutics corp